Enoxaparin in cardiovascular disease: how to improve effectiveness and safety?

Enoxaparin in cardiovascular disease: how to improve effectiveness and safety?

The review analyses the specifics of enoxaparin therapy in the most prevalent cardiovascular diseases, such as acute coronary syndrome, venous thromboembolism, and atrial fibrillation. The decision strategy is presented for difficult and non-standard clinical situations (renal dysfunction, elderly a...

Full description

Bibliographic Details
Main Author:	I. S. Yavelov
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2011-12-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	острый коронарный синдром венозные тромбоэмболические осложнения фибрилляция предсердий эноксапарин
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1980

Similar Items

MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION
by: E. A. Belikov, et al.
Published: (2015-09-01)

Is there still room for warfarin after the appearance of direct oral anticoagulants?
by: E. P. Panchenko
Published: (2023-01-01)

EFFECT OF LONG-TERM ENOXAPARIN THERAPY ON RISK OF RECURRENT VENOUS THROMBOEMBOLIC COMPLICATIONS AND RECANALIZATION OFTHROMBOSED VEINS
by: N. M. Vorobyova, et al.
Published: (2015-12-01)

Echo-cardiographic parameters for atrial fibrillation in combination with acute coronary syndrome in real clinical practice according to register of acute coronary syndrome in the Krasnodar region
by: Z. G. Tatarintseva, et al.
Published: (2019-04-01)

Профилактика венозных тромбоэмболических осложнений в хирургии
by: M. R. Kuznetsova, et al.
Published: (2018-06-01)

ВОЗМОЖНОСТИ ПРИМЕНЕНИЯ ЭНОКСАПАРИНА ПРИ ОСТРОМ КОРОНАРНОМ СИНДРОМЕ
Published: (2016-12-01)

ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY)
by: V. I. Petrov, et al.
Published: (2015-09-01)

RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE
by: I. V. Grajfer, et al.
Published: (2015-12-01)

Topical issues of dabigatran use in combination antithrombotic therapy in patients with acute coronary syndrome and nonvalvular atrial fibrillation
by: N. A. Novikova, et al.
Published: (2020-06-01)

COMPARISON OF SCHEMES OF PERIOPERATIONAL ANTICOAGULATION IN ATRIAL FIBRILLATION PATIENTS DEMANDING FOR SURGERY
by: L. N. Uddin, et al.
Published: (2018-06-01)

PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH CANCER
by: Ju. A. Fedotkina
Published: (2019-06-01)

Parenteral anticoagulants in the treatment of acute coronary syndrome: what modern clinical guidelines say
by: I. S. Yavelov
Published: (2022-06-01)

ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT
by: E. L. Dolgova, et al.
Published: (2015-09-01)

Клинико-экономическая оценка профилактики низкомолекулярными гепаринами венозных тромбоэмболических осложнений в хирургии
Published: (2018-06-01)

ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY
by: V. A. Sulimov, et al.
Published: (2015-09-01)

THE FIRST EXPERIENCE OF LEFT ATRIAL APPENDAGE OCCLUDING DEVICES IMPLANTATION FOR PREVENTION OF STROKE IN THE STATE RESEARCH CENTRE FOR PREVENTIVE MEDICINE
by: K. V. Davtyan, et al.
Published: (2015-09-01)

Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events
by: O. V. Shatalova
Published: (2015-12-01)

Risk of postoperative venous thromboembolic complication development in elderly patients
by: N. M. Krasnova, et al.
Published: (2018-03-01)

CLINICAL ANALYSIS OF A PATIENT WITH ANTIPHOSPHOLIPID SYNDROME AND SUB-MASSIVE PULMONARY EMBOLISM
by: E. N. Krivosheeva, et al.
Published: (2018-05-01)

CLINICAL DISCUSSION OF A PATIENT WITH RECURRENT VENOUS THROMBOEMBOLIC COMPLICATIONS
by: A. L. KOMAROV
Published: (2017-12-01)

Risk of venous thromboembolism in patients with pancreatic cancer
by: O. I. Kit, et al.
Published: (2022-06-01)

Anticoagulants and antiaggregants in the COVID-19 era
by: A. D. Erlikh
Published: (2021-07-01)

Results bivalirudin use in actual practice in patients with acute coronary syndrome during percutaneous coronary intervention
by: Z H Shugushev, et al.
Published: (2014-12-01)

Regarding the choice of Р2У<sub>12</sub> platelet receptor blocker in the early invasive approach to acute coronary syndrome treatment in patients without indications for long-term anticoagulant use
by: I. S. Yavelov
Published: (2020-12-01)

Фармакоэпидемиологическая и клинико-экономическая оценка профилактики венозных тромбоэмболических осложнений (реальная практика назначений)
Published: (2018-06-01)

RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID
by: N. F. Puchinyan, et al.
Published: (2016-01-01)

Prospective study one-year clinical outcomes of the Calypso coronary stent in patients presenting with acute coronary syndrome
by: В. Л. Воробьев, et al.
Published: (2017-04-01)

EXTENDED ANTICOAGULANT THERAPYIN PATIENTS, WHO SURVIVED PULMONARY EMBOLISM
by: Natalia M. Vorobieva, et al.
Published: (2018-12-01)

Formalised assessment of systemic thrombogenicity in patients with Polycythemia vera suffered an ischemic stroke
by: E. V. Roitman, et al.
Published: (2020-12-01)

Pharmacoeconomic evaluation of apixaban use for the treatment and prevention of venous thromboembolism in the general population and patients with oncological diseases
by: A. S. Kolbin, et al.
Published: (2023-03-01)

Low molecular weight heparin zibor: experience of administration in surgical practice
by: M. N. Kudykin
Published: (2017-12-01)

CОВРЕМЕННЫЕ СТРАТЕГИИ ПРОФИЛАКТИКИ ТРОМБОЭМБОЛИЧЕСКИХ ОСЛОЖНЕНИЙ У ПАЦИЕНТОВ С ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ
Published: (2016-12-01)

ПАЦИЕНТ С МЕРЦАТЕЛЬНОЙ АРИТМИЕЙ НА АМБУЛАТОРНОМ ПРИЁМЕ У ТЕРАПЕВТА
by: А. Л. Вёрткин, et al.
Published: (2013-06-01)

SECONDARY PREVENTION OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: THE CLINICIANS’ VIEWPOINT
by: E. A. Drozdova
Published: (2015-09-01)

РАЗБОР КЛИНИЧЕСКОГО СЛУЧАЯ ЛЕЧЕНИЯ ПАЦИЕНТКИ С РЕЦИДИВИРУЮЩИМИ ВЕНОЗНЫМИ ТРОМБОЭМБОЛИЧЕСКИМИ ОСЛОЖНЕНИЯМИ И ХРОНИЧЕСКОЙ ПОСТТРОМБОЭМБОЛИЧЕСКОЙ ЛЕГОЧНОЙ ГИПЕРТЕНЗИЕЙ
Published: (2014-12-01)

DABIGATRAN ETEXILATE FOR THE TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS
by: N. M. Vorobieva, et al.
Published: (2015-12-01)

ANTICOAGULANTS IN ACUTE CORONARY SYNDROME
by: I. A. Latfullin, et al.
Published: (2016-01-01)

TO THE QUESTION OF EFFICACY AND SAFETY OF FORTELYZIN® THERAPY ON ACUTE CORONARY SYNDROME: TWO CLINICAL CASES
by: D. S. Yunevich, et al.
Published: (2018-03-01)

SECONDARY MITOCHONDRIAL DYSFUNCTION IN ACUTE CORONARY SYNDROME
by: Y. A. Vasyuk, et al.
Published: (2015-12-01)

The role of clopidogrel in the current treatment of acute coronary syndrome
by: I. S. Yavelov
Published: (2020-06-01)